cobalt has been researched along with Neointima in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abekura, Y; Akiyama, R; Ishii, A; Miyamoto, S; Nishi, H; Okawa, M; Sakurai, S; Sasaki, N; Tsuji, H; Yagi, S | 1 |
| Anderson, R; Asano, T; Baumbach, A; Johnson, T; Kiemeneij, F; Lansky, AJ; Onuma, Y; Serruys, PW; Slagboom, T; Van Royen, N; Vlachojannis, G; Wijns, W; Xu, B; Zheng, M | 1 |
| Beleslin, B; Carrie, D; Danzi, GB; Iniguez, A; Macaya, C; Mehmedbegovic, Z; Moreno, R; Putnikovic, B; Schächinger, V; Zeymer, U | 1 |
| Fraccaro, C; Grossi, P; Mariani, L; Moretti, L; Silenzi, S; Vagnarelli, F | 1 |
| Ako, J; Fitzgerald, PJ; Hasegawa, T; Hirohata, A; Honda, Y; Kaneda, H; Otake, H; Sakurai, R; Waseda, K | 1 |
2 trial(s) available for cobalt and Neointima
| Article | Year |
|---|---|
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic le
Topics: Atherosclerosis; Chromium; Cobalt; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Europe; Humans; Neointima; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome | 2018 |
Cobalt-chromium KAname™ coRonary stEnt system in the treatment of patients with coronary artery disease (KARE study).
Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; France; Humans; Hyperplasia; Male; Middle Aged; Neointima; Prospective Studies; Stents | 2014 |
3 other study(ies) available for cobalt and Neointima
| Article | Year |
|---|---|
Bioresorbable Poly (L-Lactic Acid) Flow Diverter Versus Cobalt-Chromium Flow Diverter: In Vitro and In Vivo Analysis.
Topics: Absorbable Implants; Animals; Chromium; Cobalt; Endovascular Procedures; Intracranial Aneurysm; Lactic Acid; Neointima; Rabbits; Stents; Treatment Outcome; Vascular Diseases | 2023 |
Effect on Clinical Restenosis of an Ultra-Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Thin-Strut Stainless Steel Stent.
Topics: Aged; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Stainless Steel; Stents; Treatment Outcome | 2016 |
Neointimal hyperplasia in a thin-strut cobalt-chromium stent: insights from detailed 3-D intravascular ultrasound analysis.
Topics: Aged; Chromium; Cobalt; Female; Humans; Hyperplasia; Imaging, Three-Dimensional; Male; Middle Aged; Neointima; Stents; Ultrasonography, Interventional | 2010 |